Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us
Laughing child leaning back on woman's knee

Re-analysis of genomic data from Epileptic Encephalopathy Flagship

Home Research projects using our data Re-analysis of genomic data from Epileptic…

Primary organisation: University of Melbourne

Principal Investigator: Professor Ingrid Scheffer

Flagship requested: Brain malformations, Epileptic encephalopathy

Approval date: August 2020 

Applicant’s project summary:

Epilepsies are debilitating and often prolonged conditions, with numerous comorbidities. There are over 300 known epilepsy disease genes with over a third of patients being drug-resistant. Increasingly, genetic diagnosis guides the choice of the most effective therapy, however in clinical practice access to genetic testing is limited at best. Australian Genomics Epilptic Encephalopathy Flagship focused on epileptic encephalopathies as the disease group for which genomic testing is expected to make the most impact. Finding the pathogenic mutations will have direct implications for clinical practice, such as decisions about potential epilepsy surgery, and counselling of family members. For those participants with epilepsy that did not receive a diagnosis from their Flagship’s primary analysis, this project will re-analyse their genomic data with alternative pipelines and will look more broadly at genes that could contribute to their condition.


More projects

Australian Genomics and RCPA Quality Assurance Program: developing an interpretive module for genomic testing for Childhood Syndromes and ID (Medicare item: 73358)

QUality Of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA) – Paediatric Quality of Life Multi-instrument Comparison Study

An international whole genome study to definitively map heritable risk in sarcomas

Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.